These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 7662229

  • 21. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
    Kerstens MN, Buter H, Navis GJ, Dullaart RP.
    Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
    [Abstract] [Full Text] [Related]

  • 22. Effect of glycyrrhizin on cortisol metabolism in humans.
    Soma R, Ikeda M, Morise T, Miyamori I, Takeda R.
    Endocr Regul; 1994 Mar; 28(1):31-4. PubMed ID: 7949011
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Quantification of cortisol inactivation in cirrhosis of the liver.
    Vogeser M, Fischer G, Jacob K.
    Exp Clin Endocrinol Diabetes; 1998 Mar; 106(5):410-4. PubMed ID: 9831307
    [Abstract] [Full Text] [Related]

  • 25. Urinary free cortisol is not a biochemical marker of hypertension.
    Krall P, Carvajal C, Ortiz E, Muñoz C, Garrido JL, Mosso L, Fardella C.
    Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
    [Abstract] [Full Text] [Related]

  • 26. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
    Stewart PM, Burra P, Shackleton CH, Sheppard MC, Elias E.
    J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
    [Abstract] [Full Text] [Related]

  • 27. [Hypertension caused by licorice consumption].
    Seelen MA, de Meijer PH, Braun J, Swinkels LM, Waanders H, Meinders AE.
    Ned Tijdschr Geneeskd; 1996 Dec 28; 140(52):2632-5. PubMed ID: 9026743
    [Abstract] [Full Text] [Related]

  • 28. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
    Kerstens MN, Dullaart RP.
    Ned Tijdschr Geneeskd; 1999 Mar 06; 143(10):509-14. PubMed ID: 10321259
    [Abstract] [Full Text] [Related]

  • 29. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G, Beauchemin M, Vinay P, Gougoux A.
    Can Med Assoc J; 1980 Apr 19; 122(8):905-7. PubMed ID: 7370875
    [Abstract] [Full Text] [Related]

  • 30. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M, Saint-Jacques I, Morineau G, Soliman H, Julien R, Fiet J.
    Eur J Endocrinol; 1996 Aug 19; 135(2):238-44. PubMed ID: 8810740
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Correlation between decrease of 11beta-hydroxysteroid dehydrogenase activity and hypokalemia induced by furosemide in rats.
    Yao B, Zhang YD, Shen JP.
    Acta Pharmacol Sin; 2001 Nov 19; 22(11):991-6. PubMed ID: 11749789
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension.
    Madias JE, Madias NE, Gavras HP.
    Arch Intern Med; 1984 Nov 19; 144(11):2171-6. PubMed ID: 6497518
    [Abstract] [Full Text] [Related]

  • 35. Salt substitute as potassium replacement in hypertensive patients.
    Perry RS.
    Clin Pharm; 1986 Feb 19; 5(2):156-9. PubMed ID: 3956125
    [No Abstract] [Full Text] [Related]

  • 36. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ.
    Psychosom Med; 2006 Feb 19; 68(4):578-82. PubMed ID: 16868267
    [Abstract] [Full Text] [Related]

  • 37. A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid.
    Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J.
    Toxicol Appl Pharmacol; 2001 Jan 01; 170(1):46-55. PubMed ID: 11141355
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K, Remer T, Haupt A, Gallwitz B, Fritsche A, Häring HU, Maser-Gluth C.
    Obesity (Silver Spring); 2008 Jun 01; 16(6):1256-60. PubMed ID: 18421276
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.